We invite you to attend Metabolomics 2017, an exciting scientific program comprising 27 oral sessions, 5 plenaries, 4 poster sessions, sponsored luncheons, as well as several keynote lectures and workshops. We will continue the successful tradition of satellite workshops to the conference in the afternoon of Sunday 25th June and the morning of Monday 26th June. Additionally, we have planned a range of social activities, including a welcome reception, an early-career researcher mixer and a conference dinner in the iconic BCEC Plaza Ballroom to give you a true Aussie-style experience.
The conference has the theme of “Building Bridges” and under this banner extends its reach to the systems biology/genome-scale modelling community, as well as to the analytical chemistry/natural products chemistry community. In addition, the program features thematic streams for advancing the field, for food and environmental metabolomics, and for health and wellness. In addition, a deeper engagement between researchers within the Asia Pacific region is a natural focus for a conference held in Brisbane to promote metabolomics research, build and strengthen networks in the region.
Brisbane is the ideal opportunity for delegates to enjoy a microcosm of Australia’s iconic experiences. World heritage listed rainforests, amazing beaches, islands, wineries and the internationally famous Australia Zoo—home of the crocodile hunter—are all easily accessible within an hour of the city. You can even do day trips to the Barrier Reef from Brisbane.
On behalf of the Local Organising Committee and the Metabolomics Society Board we are excited to once again invite you to Metabolomics 2017—we are looking forward to welcoming you down under!
Recent advancements in diagnostics for infectious diseases and oncology are clear indicators of potential of IVD industry. The new scope of mass spectrometry, condition-specific biomarkers and NGS with advances in genomics and proteomics are tending to growing preference for rapid diagnostics, early detection and point-of-care testing.
In Vitro Diagnostics: Infectious Diseases and Oncology Conference to be held on13th -14th July 2017 in Philadelphia, USA aims to bring different stakeholders together from hospitals, laboratories academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.
The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought to light issues regarding regulations and their intricacies and boosted news trends in immuno-oncology, immuno- therapies, data interpretation and unconventional design of clinical trials.
MarketsandMarkets is pleased to announce the 'Next Generation Companion Diagnostics Conference’ on 13th – 14th July, 2017 in Philadelphia, USA which will congregate experts from the field of personalized medicine and precision medicine from pharmaceutical and academic institutes and understand the emerging trends and challenges from their perspective.
The International Conference On Nanomedicine And Nanobiotechnology is an annual event that hosts high-profile plenary speakers, world-class researchers, oral and poster presentations, workshops, sponsor exhibits and afterworks. It is a great opportunity to share your research findings with a wide audience, promote knowledge exchange, and network.
Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.
5 Interactive Streams:
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.
Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers
8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.For further information, click here: http://bit.ly/22r99ki